Dr. Liana Patt (PhD, MBA), CEO
Before leading Integra, Dr. Patt held the position of VP Business Development, Global Branded Products at Teva Pharmaceutical Industries, where she led teams of search & evaluation and early stage drug development and business transactions.
Dr. Patt managed a global team (US, Europe, Israel) and was responsible for evaluating hundreds of business opportunities in diverse therapeutic fields and various development stages, technologically, medically and commercially, out of which, selected technologies entered various types of business transactions (licensing, investments and small scale acquisitions). Dr. Patt received her PhD in Organic Chemistry from the Weizmann Institute of Science and an MBA from Edinburgh Business School, Heriott-Watt University.
Mr. Lior Buchman (CPA), CFO
Before joining Integra, Mr. Buchman served as CFO of various international life sciences companies. Mr. Buchman has over 20 years of experience in senior corporate financing, mergers & acquisitions, investor relations, operational and business development. Mr. Buchman has extensive experience in equity and debt financing with over $120 Million aggregate capital raised and M&A including post-closing integration into the acquiring organizations.
Mr. Buchman is a CPA with a BA in Accounting and Economics from the University of Haifa.